NanoFUSE Biologics named Darren Lebl, MD, to its scientific advisory board.
Four things to know:
1. Dr. Lebl is an associate professor of spine surgery and maintains a minimally invasive spine surgery practice at New York City-based Hospital for Special Surgery. He focuses on motion preservation and robotic-guided navigation surgery.
2. In this advisory board role, Dr. Lebl will contribute his expertise to NanoFUSE, which has the only FDA-cleared bioactive glass and demineralized bone matrix combined device.
3. Beyond his medical degree, which he earned from Stanford (Calif.) School of Medicine, Dr. Lebl earned degrees in biochemistry and molecular biology, chemistry and economics from the University of Chicago. He has also undergone advanced training for cervical spine disorder treatment.
4. NanoFUSE Biologics is a portfolio company of KICVentures and distributed by SpineFrontier.
More articles on biologics:
Dr. Tony Mork: Reimbursement, lack of training shackles progress of endoscopic spine surgery
Neurosurgeon Dr. Griff Harsh joins ownership group of MLS franchise
DePuy Synthes recalls devices used in spine fixation system: 6 things to know